1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1

Details for Australian Patent Application No. 2009221089 (hide)

Owner Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.

Inventors Cazzolla, Nicola; Furlotti, Guido; Guglielmotti, Angelo; Garofalo, Barbara; Mangano, Giorgina

Agent Griffith Hack

Pub. Number AU-A-2009221089

PCT Pub. Number WO2009/109618

Priority 08425139.6 07.03.08 EP

Filing date 5 March 2009

Wipo publication date 11 September 2009

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

5 August 2010 PCT application entered the National Phase

  PCT publication WO2009/109618 Priority application(s): WO2009/109618

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221091-Process for preparing enantiomerically pure indolopyridines

2009221087-1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40